Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
Clinical trial NCT03604198 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03604198
- Sponsor
- Corcept Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-07
- Primary completion
- 2026-12-01
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.